Publication

Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes

Graph Chatbot

Chat with Graph Search

Methanobrevibacter smithii ( m. smithii) for use as a biomarker and in the diagnosis and the treatment of disorders associated with aberrant microbiota and/or archaea-deficiency

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

Enhancing T-cell response in cancer immunotherapy using nanoparticles

S-acylation by ZDHHC20 targets ORAI1 channels to lipid rafts for efficient Ca2+ signaling by Jurkat T cell receptors at the immune synapse

Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link

Biotechnologies to tackle the challenge of neoantigen identification

New roles of the lymphatic endothelium in modulating adaptive immunity: implications for immune tolerance and cancer immunotherapy

Introducing tolerance to foreign and partly foreign proteins by erythrocyte binding and artificial glycosylations

Investigating the Biological Mechanisms underlying the Initiation of Autoimmunity against Beta Cell Antigens in Type 1 Diabetes